IMV is a Canada-based biopharmaceutical company that researches and develops novel immunotherapies for the treatment of cancer and infectious diseases.
Business Model:
Revenue: $212k
Employees: 51-200
Address: 130 Eileen Stubbs Avenue
City: Dartmouth
State: nova scotia
Zip: B3B 2C4
Country: CA
IMV is a Canada-based biopharmaceutical company that researches and develops novel immunotherapies for the treatment of cancer and infectious diseases.
Contact Phone:
+19024921819
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
10/9/2009
Ticker Symbol:
IMV
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2020 | Post-IPO Equity | 2 | $25.1M |
Fonds de solidarité FTQ Lumira Ventures Fonds de solidarité FTQ Lumira Ventures Fonds de solidarité FTQ Lumira Ventures Fonds de solidarité FTQ Lumira Ventures |
7/2021 | Post-IPO Equity | $25M | 8/2020 | Equity | $3.1M | 5/2020 | Private Placement | $17.8M | 12/2022 | Post-IPO Equity | $9M | 12/2021 | Post-IPO Debt | $25M |
Horizon Technology Finance Corporation Horizon Technology Finance Corporation |
3/2019 | Post-IPO Equity | 1 | $29.5M |
Fonds de solidarité FTQ Fonds de solidarité FTQ Fonds de solidarité FTQ Fonds de solidarité FTQ |
12/2022 | Post-IPO Equity | $9M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|